| For: | Yang FY, Shao L, Su J, Zhang ZM. Carrimycin in the treatment of acute promyelocytic leukemia combined with pulmonary tuberculosis: A case report. World J Clin Cases 2024; 12(3): 623-629 [PMID: 38322455 DOI: 10.12998/wjcc.v12.i3.623] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i3/623.htm |
| Number | Citing Articles |
| 1 |
Zimo Wang, Xiaodong Li, Weiyan Zhang, Lei Fu, Xinda Li, Xiaoyou Chen, Yu Lu, Rosemary C. She.
Efficacy of carrimycin against
Mycobacterium avium
complex
in vitro
and
in vivo
. Microbiology Spectrum 2025; 13(9) doi: 10.1128/spectrum.02422-24
|
| 2 |
V. V. Tinkova, L. D. Nazarova, P. V. Senchikhin, N. V. Kuzmina, M. A. Bulgakov. A Clinical Case of Successful Treatment of Generalized Tuberculosis in a Patient with Promyelocytic Leukemia. Tuberculosis and Lung Diseases 2025; 103(4) doi: 10.58838/2075-1230-2025-103-4-82-91
|
| 3 |
|
| 4 |
Luca Guarnera, Emiliano Fabiani, Giulia Falconi, Giorgia Silvestrini, Maria Luigia Catanoso, Mariadomenica Divona, Maria Teresa Voso. Acute Promyelocytic Leukemia-like AML: Genetic Perspective and Clinical Implications. Cancers 2024; 16(24) doi: 10.3390/cancers16244192
|
| 5 |
Ning Du, Dan You, Dava Tenzing, Dongxiang Qu, Jun Meng, Yihui Wang, Juan He. Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection. Infection and Drug Resistance 2024; doi: 10.2147/IDR.S468413
|